Related Experiment Video
Updated: Sep 16, 2025

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
Published on: June 13, 2025
Leveraging generative AI to assist biocuration of medical actions for rare disease
Enock Niyonkuru1,2,3, J Harry Caufield3, Leigh C Carmody2
1Trinity College, Hartford, CT 06106, United States.
Motivation:
Structured representations of clinical data can support computational analysis of individuals and cohorts, and ontologies representing disease entities and phenotypic abnormalities are now commonly used for translational research. The Medical Action Ontology (MAxO) provides a computational representation of treatments and other actions taken for clinical management. Currently, manual biocuration is used to annotate MAxO terms to rare diseases. However, it is challenging to scale manual curation to comprehensively capture information about medical actions for the more than 10 000 rare diseases.
Results:
We present AutoMAxO, a semi-automated workflow that leverages Large Language Models (LLMs) to streamline MAxO biocuration. AutoMAxO first uses LLMs to retrieve candidate curations from abstracts of relevant publications. Next, the candidate curations are matched to ontology terms from MAxO, Human Phenotype Ontology (HPO), and MONDO disease ontology via a combination of LLMs and post-processing techniques. Finally, the matched terms are presented in a structured form to a human curator for approval. We used this approach to process abstracts related to 37 rare genetic diseases and identified 958 novel treatment annotations that were transferred to the MAxO annotation dataset.
Availability And Implementation:
AutoMAxO is a Python package freely available at https://github.com/monarch-initiative/automaxo.
Related Concept Videos
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Microorganisms in Medicine and Therapeutics
CRISPR
Genomics

